期刊： EPIDEMIOLOGIC REVIEWS, 2023; 45 (1)
Asians are likely to experience a high burden of chronic conditions, including, but not limited to, diabetes, cardiovascular disease, and cancer, due ......
期刊： EPIDEMIOLOGIC REVIEWS, 2023; 45 (1)
Critical analysis of the determinants of current and changing racialized health inequities, including the central role of racism, is an urgent priorit......
期刊： EPIDEMIOLOGIC REVIEWS, 2023; 45 (1)
Although the literature on the differences between Black people and White people in terms of differences in major depressive disorder and related self......
期刊： EPIDEMIOLOGIC REVIEWS, 2023; 45 (1)
To mitigate the structural and institutional biases that contribute to inequities in health, we need a diverse cadre of individuals to feel included a......
期刊： EPIDEMIOLOGIC REVIEWS, 2023; 45 (1)
Improving race and ethnicity (hereafter, race/ethnicity) data quality is imperative to ensure underserved populations are represented in data sets use......
期刊： EPIDEMIOLOGIC REVIEWS, 2023; 45 (1)
Indigenous people are often misracialized as other racial or ethnic identities in population health research. This misclassification leads to underest......
期刊： EPIDEMIOLOGIC REVIEWS, 2023; 45 (1)
There is limited literature on the measures and metrics used to examine racism in the health inequities literature. Health inequities research is cont......
期刊： EPIDEMIOLOGIC REVIEWS, 2023; 45 (1)
Race is a social construct, commonly used in epidemiologic research to adjust for confounding. However, adjustment of race may mask racial disparities......
期刊： EPIDEMIOLOGIC REVIEWS, 2022; 44 (1)
Although observational studies have identified modifiable risk factors for Alzheimer disease and related dementias (ADRD), randomized controlled trial......
期刊： EPIDEMIOLOGIC REVIEWS, 2022; 44 (1)
The COVID-19 pandemic revealed weaknesses in the public health infrastructure of the United States, including persistent barriers to engaging marginal......
期刊： EPIDEMIOLOGIC REVIEWS, 2022; 44 (1)
In trials of infectious disease interventions, rare outcomes and unpredictable spatiotemporal variation can introduce bias, reduce statistical power, ......
期刊： EPIDEMIOLOGIC REVIEWS, 2022; 44 (1)
Clinical trials are considered the gold standard for establishing efficacy of health interventions, thus determining which interventions are brought t......
期刊： EPIDEMIOLOGIC REVIEWS, 2022; 44 (1)
Randomized trials are often designed to collect outcomes at fixed points in time after randomization. In practice, the number and timing of outcome as......
期刊： EPIDEMIOLOGIC REVIEWS, 2022; 44 (1)
In clinical trials, harms (i.e., adverse events) are often reported by simply counting the number of people who experienced each event. Reporting only......
